US 11,738,146 B2
Drug delivery system and method of use
Adam B. McCullough, Westlake Village, CA (US); Ferry Tamtoro, San Ramon, CA (US); Huaying Yang, Vernon Hills, IL (US); Mark Ka Lai Lee, Newbury Park, CA (US); Desheng Yin, Thousand Oaks, CA (US); Scott R. Gibson, Granada Hills, CA (US); Donald Busby, Thousand Oaks, CA (US); Peter V. Shultz, Woodland Hills, CA (US); Keith P. Kogler, Simi Valley, CA (US); Jimmie L. Ward, Golden, CO (US); Christopher R. Folk, San Diego, CA (US); and Steven William Badelt, Los Angeles, CA (US)
Assigned to AMGEN INC., Thousand Oaks, CA (US)
Filed by AMGEN INC., Thousand Oaks, CA (US)
Filed on May 13, 2020, as Appl. No. 15/931,364.
Application 15/931,364 is a continuation of application No. 15/315,817, granted, now 10,695,492, previously published as PCT/US2015/033925, filed on Jun. 3, 2015.
Claims priority of provisional application 62/007,007, filed on Jun. 3, 2014.
Prior Publication US 2020/0268969 A1, Aug. 27, 2020
Int. Cl. A61M 5/20 (2006.01); A61M 5/315 (2006.01); A61M 5/32 (2006.01); A61M 5/142 (2006.01); A61M 5/50 (2006.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); G16H 40/00 (2018.01); G16H 40/67 (2018.01); G06Q 50/22 (2018.01); G06Q 50/00 (2012.01); A61M 5/158 (2006.01); A61M 5/24 (2006.01)
CPC A61M 5/20 (2013.01) [A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/158 (2013.01); A61M 5/24 (2013.01); A61M 5/31501 (2013.01); A61M 5/31568 (2013.01); A61M 5/3202 (2013.01); A61M 5/326 (2013.01); A61M 5/3243 (2013.01); A61M 5/3257 (2013.01); A61M 5/5086 (2013.01); G06Q 50/01 (2013.01); G06Q 50/22 (2013.01); G16H 20/17 (2018.01); G16H 40/00 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); A61M 2005/3267 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3576 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2205/6009 (2013.01)] 16 Claims
OG exemplary drawing
 
1. A drug delivery device comprising:
a housing having an exterior surface;
an opening formed in the exterior surface of the housing;
a reservoir disposed at least partially within the housing;
a delivery member having a proximal end connected or configured to be connected in fluid communication with the reservoir and a distal end configured to extend through the opening in an operative state;
an adhesive disposed at the exterior surface of the housing for releasably attaching the drug delivery device to skin of a patient;
a removable cover coupled with the housing;
an electrical skin contact sensor disposed at the exterior surface of the housing; and
the drug delivery device being configured or programmed to:
(a) determine if the removable cover has been removed from the housing prior to or independent of use of the electrical skin contact sensor for sensing contact with the skin of the patient,
(b) alert the patient if or when the removable cover has been removed from the housing, and
(c) subsequent to (b), alert the patient if or when the drug delivery device has been triggered to deliver a drug to the patient.